ABG 30 (Morphine sulphate extended-release 30 mg)
Pill imprint ABG 30 has been identified as Morphine sulphate extended-release 30 mg.
Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Images for ABG 30 (Morphine sulphate extended-release 30 mg)
- 30 mg
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00591-3741||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
|66336-0173||Dispensing Solutions Inc. (repackager)|
|49999-0846||Lake Erie Medical and Surgical Supply (repackager)|
|55887-0092||Diversified Healthcare Services Inc (repackager)|
|10544-0379||Blenheim Pharmacal Inc (repackager)|
|16590-0607||Stat RX USA LLC (repackager)|
|54868-4033||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...